H. Tsukamoto

Development of human-human hybridoma from anti-Her-2 peptide-producing B cells in immunized NOG mouse.

Mamoru Ito, N. Tamaoki, K. Imai, 2006, Experimental hematology.

Functional CD5+ B cells develop predominantly in the spleen of NOD/SCID/gammac(null) (NOG) mice transplanted either with human umbilical cord blood, bone marrow, or mobilized peripheral blood CD34+ cells.

Mamoru Ito, K. Ando, Y. Kametani, 2003, Experimental hematology.

Tumor-associated glycoantigen, sialyl Lewis(a) as a target for bispecific antibody-directed adoptive tumor immunotherapy.

S. Habu, N. Hanai, T. Nishimura, 1995, Immunology letters.

Human C‐ERBB‐2 proto‐oncogene product as a target for bispecific‐antibody‐directed adoptive tumor immunotherapy

T. Masuko, Y. Takeuchi, Tadashi Yamamoto, 1992, International journal of cancer.

Specific targeting of in vitro‐activated human antitumour effector cells using anti‐CD3 × anti‐c‐erbB‐2 bispecific antibody

T. Masuko, Y. Hashimoto, S. Habu, 1993, Immunology and cell biology.

Large-scale culture system of human CD4+ helper/killer T cells for the application to adoptive tumour immunotherapy.

S. Habu, Y. Nakamura, T. Nishimura, 1992, British Journal of Cancer.

Matched sibling donor stem cell transplantation for Fanconi anemia patients with T‐cell somatic mosaicism

S. Kato, M. Takata, K. Oshima, 2012, Pediatric transplantation.